myelodysplastic syndrome (mds)
Showing 1 - 25 of 77
Refine and Assess Readability of Patient, Carer, and Clinician
Completed
- Myelodysplastic Syndrome (MDS)
- Carer Treatment Preference Myelodysplasia Questionnaire
- +2 more
-
Newcastle, New South Wales, AustraliaCalvary Mater Newcastle
Apr 4, 2023
Myelodysplastic Syndrome (MDS) Trial in Worldwide (sabatolimab, azacitidine, venetoclax)
Active, not recruiting
- Myelodysplastic Syndrome (MDS)
- sabatolimab
- +2 more
-
Brasschaat, Belgium
- +9 more
Jan 19, 2023
Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Minneapolis (N-803)
Completed
- Acute Myelogenous Leukemia (AML)
- Myelodysplastic Syndrome (MDS)
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Jan 4, 2023
Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Hematopoietic Stem Cell Transplant (HSCT) Trial in Pittsburgh
Active, not recruiting
- Acute Myeloid Leukemia (AML)
- +2 more
- Reduced-Intensity Conditioning Regimen
- Myeloablative Conditioning Regimen
-
Pittsburgh, PennsylvaniaUPMC Children's Hospital of Pittsburgh
Jan 4, 2023
Acute Myeloid Leukaemia (AML), Myelodysplastic Syndrome (MDS), Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Trial
Not yet recruiting
- Acute Myeloid Leukaemia (AML)
- +2 more
- (no location specified)
Sep 6, 2022
Myelodysplastic Syndrome (MDS) Trial in Worldwide (Venetoclax, Azacitidine, Placebo)
Active, not recruiting
- Myelodysplastic Syndrome (MDS)
- Venetoclax
- +2 more
-
Fullerton, California
- +219 more
Aug 24, 2022
Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Worldwide (Lemzoparlimab, Azacitidine, Venetoclax)
Recruiting
- Acute Myeloid Leukemia (AML)
- Myelodysplastic Syndrome (MDS)
- Lemzoparlimab
- +2 more
-
Birmingham, Alabama
- +35 more
Aug 19, 2022
Myelodysplastic Syndrome (MDS) Trial in Yamagata (ASTX030)
Recruiting
- Myelodysplastic Syndrome (MDS)
-
Yamagata, JapanYamagata University Hospital
Jun 20, 2022
Acute Myeloid Leukaemia (AML), Myelodysplastic Syndrome (MDS) Trial in Worldwide (S64315 once a week, S64315 twice a week)
Completed
- Acute Myeloid Leukaemia (AML)
- Myelodysplastic Syndrome (MDS)
- S64315 once a week
- S64315 twice a week
-
New Haven, Connecticut
- +8 more
May 17, 2022
Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Myeloproliferative Tumor (MDS/MPN) Trial in Durham (ADCT-301)
Recruiting
- Acute Myeloid Leukemia (AML)
- +2 more
-
Durham, North CarolinaDuke University Health System
Jan 10, 2022
Myelodysplastic Syndrome (MDS) Trial in United States (AMV564 14-Day CIV)
Completed
- Myelodysplastic Syndrome (MDS)
- AMV564 14-Day CIV
-
Duarte, California
- +4 more
Oct 11, 2021
Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Recruiting
- Myelodysplastic Syndrome (MDS)
- +3 more
- Cord Blood Transplant
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 22, 2021
Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Maywood, Durham
Completed
- Acute Lymphoblastic Leukemia (ALL)
- +4 more
-
Maywood, Illinois
- +1 more
Aug 1, 2021
Myelodysplastic Syndrome (MDS) Trial (FF-10501-01, Azacitidine)
Withdrawn
- Myelodysplastic Syndrome (MDS)
- (no location specified)
Jul 20, 2021
Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial run by the NHLBI
Completed
- Myelodysplastic Syndrome (MDS)
- +2 more
- WT1:126-134
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 15, 2021
Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML) Trial in Tampa (PF-04449913)
Completed
- Myelodysplastic Syndrome (MDS)
- Chronic Myelomonocytic Leukemia (CMML)
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jun 10, 2021
Myelodysplastic Syndrome (MDS) Trial in Cleveland (CPX-351)
Recruiting
- Myelodysplastic Syndrome (MDS)
-
Cleveland, OhioCleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Apr 21, 2021
Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Chicago (Haplo-Cord Transplant, Matched Unrelated Donor
Terminated
- Acute Myeloid Leukemia (AML)
- Myelodysplastic Syndrome (MDS)
- Haplo-Cord Transplant
- Matched Unrelated Donor Transplant
-
Chicago, IllinoisUniversity of Chicago Cancer Center
Feb 22, 2021
Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in United States (Infusion of NEXI-001 T Cells)
Recruiting
- Acute Myeloid Leukemia (AML)
- Myelodysplastic Syndrome (MDS)
- Infusion of NEXI-001 T Cells
-
Duarte, California
- +4 more
Feb 16, 2021
Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML) Trial in Worldwide (NiCord®
Active, not recruiting
- Hematological Malignancies
- +6 more
- NiCord® (omidubicel)
- Cord Blood Unit
-
Los Angeles, California
- +51 more
Jan 7, 2021
Myelodysplastic Syndrome (MDS), Chronic Lymphocytic Leukemia (CLL), Chemo-sensitive Lymphoma Trial in United States (drug,
Completed
- Myelodysplastic Syndrome (MDS)
- +6 more
- Fludarabine
- +15 more
-
Gainesville, Florida
- +10 more
Nov 30, 2020
Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML) Trial in Worldwide (NiCord®)
Completed
- Hematological Malignancies
- +3 more
-
Los Angeles, California
- +14 more
Oct 1, 2020
Chronic Myeloid Leukemia (CML), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in New York (CliniMACS
Recruiting
- Chronic Myeloid Leukemia (CML)
- +5 more
- CliniMACS CD34+ Reagent System
- +8 more
-
New York, New YorkColumbia University Medical Center
Jun 17, 2020
Leukemia, Acute Lymphocytic (ALL), Leukemia, Myeloid, Acute(AML), Leukemia, Myeloid, Chronic(CML) Trial in Memphis (device,
Completed
- Leukemia, Acute Lymphocytic (ALL)
- +7 more
- CliniMACS
- +11 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Apr 3, 2020